drugset
Drugs / BBT001
last change 2 days ago re-read 3 minutes ago

BBT001

Developed for
atopic eczema
Investigated by
Bambusa Therapeutics

Trials 2

today NCT07239947 · Ph 1 NCT06808477 · Ph 1
20262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07239947 Aug 2025 → Aug 2026 overdue atopic eczema Bambusa Therapeutics Recruiting No outcome recorded
Phase 1 NCT06808477 Feb 2025 → Feb 2027 expected atopic eczema Bambusa Therapeutics Recruiting No outcome recorded

News releases announcing trial results or a regulatory action · 4

DateIssuerRelease
2026-07-27 Bambusa Therapeutics Results Bambusa Therapeutics Reports Potentially Transformative Preliminary Proof-of-Concept Results for BBT001 in Atopic Dermatitis, Reinforcing Its Best-in-Disease Potential bambusatx.com ↗
BBT001 delivered highly statistically significant and clinically meaningful improvement in EASI beginning at Week 1, with responses continuing to improve over time
2026-04-01 Bambusa Therapeutics Results Bambusa Therapeutics Presented Positive Results from the Phase 1 Multiple Ascending Dose Trial of BBT001 at the 2026 American Academy of Dermatology (AAD) Annual Meeting bambusatx.com ↗
2025-09-30 Bambusa Therapeutics Results Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001 bambusatx.com ↗
Last week, Bambusa Therapeutics unveiled highly positive results from the single ascending dose portion of its ongoing Phase I healthy volunteer study of BBT001 at the European Academy of Dermatology and Venereology (EADV) 2025.
2025-05-30 Bambusa Therapeutics Regulatory Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I&I Conditions and U.S. FDA Clearance of IND Application for BBT001 bambusatx.com ↗
The clearance of BBT001-01 study expands the clinical development territory of BBT001 beyond Australia into the United States

All press releases naming this drug 7 releases

DateIssuerRelease

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as BBT001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07239947 ↗
1

NCT06808477 ↗